CARDURION PHARMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 19 Nov 2025)
What this means for you
Registered since 21 Jul 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87122661
- Registration number
- 6108164
- Mark type
- Stylized text
- Filed
- 01 Aug 2016
- Published for opposition
- 20 Dec 2016
- Registered
- 21 Jul 2020
- Attorney of record
- Valerie Brennan
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical field; conducting clinical trials for others in the field of cardiovascular medicine
Owner
- Cardurion Pharmaceuticals, Inc., Burlington, MA, US
- Cardurion Pharmaceuticals, Inc., Boston, MA, US
- Cardurion Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 19 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Nov 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Aug 2025 — TEAS SECTION 8 & 15 RECEIVED
- 21 Jul 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jul 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jul 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jul 2020 — REGISTERED-PRINCIPAL REGISTER
- 16 Jun 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jun 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Jun 2020 — EXAMINER'S AMENDMENT ENTERED
- 15 Jun 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 15 Jun 2020 — EXAMINERS AMENDMENT E-MAILED
- 15 Jun 2020 — SU-EXAMINER'S AMENDMENT WRITTEN